ILF2 is upregulated in several malignancies, including liver and lung cancer, where its high expression stimulates malignant phenotypes in liver cells [32, 33] and interacts with E2F transcription factor 1 (E2F1) to promote lung cancer progression [34]. The gene discussed is ILF2; the disease is lung carcinoma.